Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
  • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
• • A—HUMAN NECESSITIES
  • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
  • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
  • A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
  • A01N35/04—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aldehyde or keto groups, or thio analogues thereof, directly attached to an aromatic ring system, e.g. acetophenone; Derivatives thereof, e.g. acetals
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
  • A61K8/34—Alcohols
  • A61K8/345—Alcohols containing more than one hydroxy group
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
  • A61K8/34—Alcohols
  • A61K8/347—Phenols
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q19/00—Preparations for care of the skin
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
  • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
  • A61K2800/52—Stabilizers
  • A61K2800/524—Preservatives

Definitions

• the present invention relates to preserved personal care product compositions and their use in personal care products applied to the human skin or scalp, and methods of making such products.
• Preservatives are used in personal care products (products applied to the skin or scalp either to remain there or to be rinsed off) to preserve these products against microbial spoilage and to extend their shelf life.
• Antimicrobial compounds used for product preservation may fall into one or more of the following classes based on the effect they have on the microorganism, in particular bacteria and fungi.
• a germistatic compound inhibits the growth of germs, while a germicidal compound kills germs.
• An antibacterial or antifungal may inhibit growth of the microorganisms or kill them or both.
• Many antimicrobial compounds are not effective against fungal spores.
• a bacteriostatic compound inhibits growth of bacteria, while a bactericide kills bacteria (reduces their number).
• a fungistatic compound inhibits the growth of fungi (molds and yeast), while a fungicide kills fungi (reduces their number).
• a sporicide kills spores of fungi or bacteria. Spores, especially endospores, are formed by some bacteria to survive during periods of deprivation and are significantly more difficult to kill. Fungi form spores for reproduction and these spores are significantly more difficult to kill than the vegetative form of the fungi.
• a broad band preservative effect including a bactericidal and fungicidal activity was previously only partially attained in personal care products, or attained only by addition of certain fungicides, in particular formaldehyde, formaldehyde donors, halogenated compounds, compounds belonging to the class of parabens and a variety of specific fungicides.
• Combinations of certain different 1,2-alkanediols or 1,2-alkanediols with certain well known preservatives, in particular phenoxyethanol or parabens are known from DE10206759, Beilfuss et al. in SOFW-Joumal 131, 11-2005, p. 30-36, WO2005/102276, WO2006/045746, EP 1537781, and EP 0524548.
• Formaldehyde donors include in particular diazolidinyl urea (CAS 78491-02-8), imidazolidinyl urea (CAS 39236-46-9), and DMDM Hydantoin (CAS 6440-58-0).
• Halogenated compounds include in particular 2,4-dichlorobenzyl-alcohol (CAS 1777-82-8), Chloroxylenol (also known as 4-chloro-3,5-dimethyl-phenol, CAS 88-04-0), Bronopol (also known as 2-bromo-2- nitropropane-1 ,3-diol, CAS 52-51-7), iodopropynyl butyl carbamate (CAS 55406-53-6).
• Chloroxylenol also known as 4-chloro-3,5-dimethyl-phenol, CAS 88-04-0
• Bronopol also known as 2-bromo-2- nitropropane-1 ,3-diol, CAS 52-51-7
• iodopropynyl butyl carbamate CAS 55406-53-6.
• Paraben compounds include in particular Methyl-paraben (CAS 99-76-3), Ethyl-paraben (CAS 120-47-8), Propyl-paraben (CAS 94-13-3), Butyl-paraben (CAS 94-26-8), Isopropyl-paraben (CAS 4191-73-5), and Benzyl-paraben (CAS 94-18-8).
• fungicides include Quaternium-15 (CAS 51229-78-8), methyl-chloroisothiazolinone (CAS 26172-55-4), and methylisothiazolinone (CAS 2682-20-4).
• fungicide compounds may constitute health hazards, for example, iodopropynyl butyl carbamate, formaldehyde and formaldehyde donors, methyl-chloroisothiazolinone (CAS 26172-55-4), and methylisothiazolinone are considered highly allergenic/sensitizing.
• Various milder preservatives are known but they do not provide a sufficient preservative effect, for example p- hydroxy-benzoic acid, methyl-paraben, ethyl-paraben, propyl-paraben, isopropyl-paraben, butyl-paraben, isobutyl-paraben, and benzyl-paraben.
• phenoxyethanol, 2-phenylethanol, and benzyl alcohol are mild to the skin and do not raise similar safety concerns as do the preservatives mentioned above.
• Applicant has now identified a composition of diol compounds according to formula I as shown herein below that, in combination with benzaldehyde and certain benzaldehyde derivative compounds of formula Il as shown herein below, provide a preservative action in personal care products and provide a broad band preservative activity including a sporicidal effect. This is important for the stability and shelf life of the product.
• benzaldehyde and benzaldehyde-derivative compounds are compounds according to formula Il as defined herein-below. They include benzaldehyde and certain benzaldehyde-derivatives whose chemical structure is shown below.
• heliotropin is known to be active as a fungistatic compound in vaporous form when applied to fungi on tobacco leaves, and to have an antifungal and antibacterial effect against some fungi and bacteria in aqueous culture media.
• the germicidal effect in particular the bactericidal and fungicidal effect, is generally considered to be low, especially when the pH is within the range commonly used in personal care products, which is pH 5 to pH 9. While some compounds are known to be more active under extremely acidic or alkaline conditions, this effect does not extend to the pH range used in personal care products.
• That compounds that are fungistatic in certain food stuffs can provide a fungicidal and sporicidal effect in personal care products that often contain lipids and proteins or a high concentration of detergents was completely surprising and could not have been predicted.
• an activity or lack of activity of a given test compound in water is not indicative of an activity in a personal care product, for example, a cosmetic cream.
• an enhancing effect when used in combination with certain known preservatives in personal care products is not predictable.
• the following known preservative compounds which also are commonly used in personal care products, may be added:
• a personal care product composition comprising
• R1 is selected from methyl, and a C1-R2, C3 (propyl), C4 (butyl), and C 6 alkane (hexyl),
• R2 is 2-ethyI-hexyloxy
• n is selected from O, and 1
• diol compound is selected from the group consisting of 1,2-pentanediol, 1,2-hexanediol, 1,2- octanediol, 2-methyl-1,3-propandiol, and 3-(2-ethyl-hexyloxy)-1,2-propandiol, and wherein the at least one compound according to formula I is present in a total concentration of 0.1 % to 2% (w/w); and
• R1 and R2 are selected from H, methyl, hydroxy, methoxy, or R1 together with R2 forms a 3,4- methylendioxy substituent, and
• R1 is H then R2 is selected from H, methyl, hydroxy, and methoxy, and
• R2 is hydroxy
• R1 is selected from H, hydroxy, and methoxy
• said compound is selected from the group consisting of benzaldehyde, 4-methylbenzaldehyde, heliotropine, vanilline, 4-hydroxybenzaldehye, 3-hydroxybenzaldehyde, 4-methoxybenzaldehyde and 3- methoxybenzaldehyde, 2,4-dihydroxybenzaldehyde, 3-hydroxy-4-methoxybenzaldehyde, 3,5- dihydroxybenzaldehyde, and 4-hydroxy-2-methoxybenzaldehyde; and
• c) optionally at least one compound selected from the group consisting of phenoxyethanol, 2-phenylethanol, and benzylalcohol, in a total concentration of 0.05 to 0.3 % (w/w);
• composition is free from a bactericidally-, fungicidally-, sporicidally-effective or preservative concentration of compounds selected from the group consisting of:
• formaldehyde a formaldehyde donor compound including diazolidinyl urea, imidazolidinyl urea, and DMDM Hydantoin
• parabens selected from the group consisting of methyl-paraben, ethyl-paraben, propyl-paraben, isopropyl- paraben, butyl-paraben, isobutyl-paraben, and benzyl-paraben.
• halogenated compound including 2,4-dichlorobenzyl-alcohol, 4-chloro-3,5-dimethyl-phenol, 2-bromo-2- nitropropane-1 ,3-diol, and iodopropynyl butyl carbamate;
• a fungicide selected from quaternium-15 (CAS 51229-78-8), methyl-chloroisothiazolinone, and methylisothiazolinone.
• a personal care product composition as hereinabove described wherein the at least one compound a) is present in a concentration selected from 0.1 to 1%, and 0.15 to 0. 5% (w/w); a personal care product composition as described above wherein the at least one compound b) is present in a concentration selected from 0.075 to 0.3%, and 0.1 to 0.2% (w/w), a personal care product composition as hereinabove described wherein the at least one compound a) is present in a concentration of 0.1 to 1% (w/w), and wherein the at least one compound b) is present in a concentration selected from 0.075 to 0.3%, and 0.1 to 0.2% (w/w), and a personal care product composition as hereinabove described wherein the at least one compound a) is present in a concentration of 0.15 to 0. 5% (w/w), and wherein the at least one compound b) is present in a concentration selected from 0.075 to 0.3%, and 0.1 to 0.2% (w/w),
• compositions as hereinabove described wherein at least one compound c) as hereinabove described is present in a concentration selected from 0.05 % to 0.3% (w/w), 0.075 to 0.25, and 0.15 to 0.2 %.
• compositions for personal care products applied to and left on the skin or scalp including creams, salves, lotions, and ointments for hand, face or body, perfumes, eau de Cologne, eau de toilet, deodorants, ahtiperspirants, and products applied to and rinsed off the skin or scalp including soaps, liquid soaps, shower gels, and shampoos.
• a personal care product comprising a personal care product composition as hereinabove described, in an application form selected from stick, roll-ons, spray, pump-spray, aerosol, soap bar, powder, solution, gel, cream, balm and lotion.
• the above lipid-comprising personal care product composition is provided in form of an emulsion.
• a method of forming a preserved personal care product composition which is sufficiently bactericidal to have a reduction factor for Pseudomonas aeruginosa and Staphylococcus aureus of at least 1000 per 7 days, and is sufficiently sporicidal to have a reduction factor of 100 per 7 days for Aspergillus niger, by admixing an effective amount of the at least one compound a) and the at least one compound b), and optionally at least one compound c) as hereinabove defined to a personal care product base, forming a personal care product composition with the proviso as hereinabove defined.
• a method of making a preserved personal care product by providing the personal care product composition formed as hereinabove described in a suitable personal care product application form that includes sticks, roll-ons, sprays, pump-sprays, aerosols, soap bars, powders, solutions, gels, creams, balms and lotions.
• Bases for personal care products are well known in the art and the resulting personal care product will usually have a pH of pH5 to pH9 (for example, slightly acidic for products applied to and left on the skin, slightly alkaline for soap products). It is also possible to employ an existing personal care product composition and simply add a) and b) and optionally c) in the concentrations hereinabove defined and mix thoroughly.
• concentration of compounds under a) and b) and optionally c) that is employed in a composition will depend upon the nature of the product and the preservative effect and length to be achieved, in particular the bactericidal, fungicidal and sporicidal activity.
• a useful concentration for the diol compound(s) a) is, for example, 0.1 to 2 %, 0.1 to 1 % or 0.15 to 0.5% (w/w).
• a useful concentration for the preservative enhancer compound(s) b) is, for example, 0.05 to 5%, 0.075 to 0.3%, or 0.1 to 0.2% (w/w).
• a useful concentration for optional mild preservative compound(s) c) is, for example 0.05 to 0.3 %, 0.075 to 0.25 %, or 0.15 to 0.2 % (w/w).
• the diol compound(s) a) and the preservative enhancer b) generally provide a sufficient bactericidal, fungicidal and sporicidal activity in a wide range of personal care product compositions.
• Optional mild preservative enhancer compounds(s) c) adds to the preservative effect when used in the concentrations indicated.
• a sufficient bactericidal activity is attained when the reduction factor is 1000 per 7 days.
• a sufficient sporicidal activity is attained when the reduction factor is 100 per 7 days.
• a sufficient sporicidal activity is strongly indicative of a sufficient fungicidal activity.
• Fungicidal activity may easily be tested on yeast strains, using a mix of three Candida strains as described in example 4.
• a sufficient fungicidal activity is reached when the reduction factor is 100 per 7 days.
• the reduction factor is determined by growing a suitable test organism ⁇ Aspergillus niger for fungi, Pseudomonas aeruginosa for gram-negative bacteria and Staphylococcus aureus for gram-positive bacteria) on a suitable culture medium on agar plates, harvesting and adding to a personal care product composition in a density of 3x10 5 organism/ml and counting the plated organisms in the probe and a negative control. The count of the negative control is divided by the count of the probe and thereby the reduction factor is determined (compare example 1).
• Preservative enhancers of particular interest are 4-hydroxybenzaldehyde and 3-hydroxybenzaldehyde, for their surprisingly good activity.
• Personal care product compositions are used to form a personal care product in an appropriate application form and packaging, as is well-known in the art.
• Personal care products and compositions to form them as described herein are used for the purpose of cleansing, conditioning, grooming, beautifying, promoting attractiveness, or otherwise enhancing or altering the appearance of the human body and are applied to the human skin or scalp.
• These include products applied to and left on the skin or scalp, for example creams, salves, lotions, and ointments for hand, face or body, perfumes, eau de Cologne, eau de toilet, deodorants, antiperspirants, and products applied but rinsed off such as soaps, liquid soaps, shower gels, shampoos.
• These products can, for example, take various forms of application, for example sticks, roll-ons, sprays, pump-sprays, aerosols, soap bars, powders, solutions, gels, creams, balms and lotions.
• Lipids are often included for example into washing formulations including liquid soaps or washing lotions to provide an oil replenishing effect.
• Preservative-enhancing compounds as hereinabove defined allow the formulation of preserved emulsions or formulations comprising lipids and/or detergents where the activity (the bactericidal, fungicidal and in particular the sporicidal effect) is not lost due to the presence of the lipid base and/or detergents or surfactants.
• compounds of the present invention may also be combined with art-recognised quantities of other excipients commonly employed in these products; useful selections may be found in « CTFA Cosmetic Ingredient Handbook » J.M. Nikitakis (ed.), 1st ed., The Cosmetic, Toiletry and Fragrance Association, Inc., Washington, 1988, which is hereby incorporated by reference.
• excipients may, for example, include colorants, fragrances, solvents, surfactants, colorants, opacifiers, buffers, antioxidants, vitamins, emulsifiers, UV absorbers, silicones and the like. All products can also be buffered to the desired pH using commonly-available excipients in a known manner.
• Aspergillus niger ATCC 16404 spores are added to water to obtain a density of 3 x 10 5 spores / ml.
• the test strain is grown for 5 days on potato dextrose agar at room temperature.
• the spores are harvested with a solution containing 0.1% Tween 80, peptone 0.1% and NaCI 0.85% and the spore concentration is adjusted to the density indicated above.
• Test compounds are dissolved in dipropyleneglycol to a concentration of 20%.
• the reduction factor is determined as follows. Aliquots of the above prepared suspension of microorganisms (here: spore suspension prepared as described above) are plated on a suitable agar medium (see above) and the developing colonies are counted both for samples with test compound and for a negative probe (water).
• the count of the negative control is divided by the count of the test compound and thereby the reduction factor is determined.
• a negative control (water) accordingly has a reduction factor of 1 (no effect on the microorganism).
• Mefranal, and and 9-decenol show a significant sporicidal effect.
• a preservative-free oil-in-water emulsion skin cream is used.
• Test samples of cream are made up to contain different amounts of diol compounds and/or benzaldehyde derivatives.
• the diol compound and the benzaldehyde derivatives is added to an aliquot of 10 g of the cream in 50 ml tubes in a concentration as shown in the table below.
• the cream is thoroughly mixed to achieve a homogeneous distribution.
• the cream is then stored for 1 - 3 days to equilibrate at room temperature (in order to achieve a homogenous partitioning of compounds between oil and water phase).
• sporicidal effect For testing of sporicidal effect, to each sample 100 ⁇ l of a spore suspension of Aspergillus niger ATCC 16404 containing 3 x 10 7 spores / ml (prepared as described in example 1) is added. After regular test intervals, samples of 1 g cream are removed and added to 20 ml of a neutralizer solution containing 0.2% lecithin, 2 % Tween 80 and 0.5% NaCI. These dilutions are vigorously shaken for 10 min until the cream is dissolved, and then aliquots of this solution are spread plated on potato dextrose agar containing 0.2% Tween 80. After 48 h to 72 h the number of surviving colony forming units (and therefore surviving spores) are counted.
• Staphylococcus aureus DSMZ 799
• Pseudomonas aeruginosa ATCC 15442
• the strains are grown overnight in Mueller-Hinton broth and adjusted to a cell density of 1 x 10 8 cfu (colony forming units) per ml.
• the two bacterial strains are mixed in a ratio of 1:1 and 100 ⁇ l of this mixed inoculum is added to 10 ml aliquots of the cosmetic cream supplemented with test compounds as described above in the concentration as indicated in the table below.
• the resulting mixtures are incubated at room temperature and at the regular intervals samples are removed, suspended in neutralizer solution and diluted as described above.
• the yeast strains are grown in Sabouraud liquid medium, washed and suspended in saline and adjusted to 5 x 10 7 cfu (colony forming units) per ml. The Inoculum of the three strains is then pooled in a ratio of 1:1:1. For determining the reduction factor by counting of the colonies formed, the samples inoculated with the yeast strains are spread plated on potato dextrose, incubated until colonies have formed and counted.
• the count of the negative control is divided by the count of the probe and thereby the reduction factor is determined.
• the negative control with no Diol and no benzaldehyde derivative by definition has a reduction factor of 1. With a benzaldehyde derivative in a concentration 0.1% but no Diol-compound present, the reduction factor is not improved, no sporicidal effect is seen at this concentration.
• the benzaldehyde derivative at a concentration of 0.1 % in combination with 1.5% of a 1 ,2- hexanediol / 1,2-octanediol mixture shows an excellent reduction factor, while the Diol-mixture shows no significant sporicidal activity at this concentration.
• the preservative-free cosmetic cream for application to the human skin is Cremor basalis (commercially available from Fagron GmbH, Barsb ⁇ ttel, Germany).
• the amounts of diol compounds and benzaldehyde derivatives that are added to an aliquot of 10 g of the cream in 50 ml tubes to give a concentration (w/w) of 0.125-4 % are as shown in the table below, as are the results obtained.
• a combination of 4-hydroxybenzaldehyde with diol-compounds gives highly efficient reduction in fungal spores of well above 100 even at comparatively low concentrations: a combination with 2% 2-methyl- 1 ,3-propandiol shows a reduction factor of >300, and a for the combination with 0.25% 1 ,2-Ocatandiol again reaches a reduction factor of >300, and 391.7 for the combination with 3-(2-ethyl-hexyloxy)-1,2-propandiol).

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Veterinary Medicine (AREA)
• Animal Behavior & Ethology (AREA)
• Public Health (AREA)
• Birds (AREA)
• Epidemiology (AREA)
• Emergency Medicine (AREA)
• Dentistry (AREA)
• Agronomy & Crop Science (AREA)
• Wood Science & Technology (AREA)
• Zoology (AREA)
• Environmental Sciences (AREA)
• Engineering & Computer Science (AREA)
• Plant Pathology (AREA)
• Dermatology (AREA)
• Agricultural Chemicals And Associated Chemicals (AREA)
• Cosmetics (AREA)
• Pest Control & Pesticides (AREA)

Priority Applications (6)

Applications Claiming Priority (2)

Publications (1)

Family

ID=37712226

Family Applications (1)

Country Status (8)

Cited By (8)

Families Citing this family (12)

Citations (9)

Family Cites Families (50)

• 2006
  • 2006-12-15 GB GB0625069A patent/GB0625069D0/en not_active Ceased
• 2007
  • 2007-12-11 WO PCT/CH2007/000627 patent/WO2008071027A1/en not_active Ceased
  • 2007-12-11 BR BRPI0720307-1A patent/BRPI0720307B1/pt active IP Right Grant
  • 2007-12-11 JP JP2009540571A patent/JP5637686B2/ja active Active
  • 2007-12-11 MX MX2009006209A patent/MX2009006209A/es active IP Right Grant
  • 2007-12-11 CN CN2007800464377A patent/CN101557707B/zh active Active
  • 2007-12-11 US US12/518,680 patent/US9192559B2/en active Active
  • 2007-12-11 EP EP07845624.1A patent/EP2099294B9/en not_active Revoked

Patent Citations (10)

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events